CFH, complement factor H, 3075

N. diseases: 393; N. variants: 150
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0025303
Disease: Meningococcal Infections
Meningococcal Infections
0.400 GeneticVariation group BEFREE The role of properdin in regulating complement in health and disease has not received as much appraisal as the many negative AP regulators, such as factor H. Historically, properdin deficiency has been strongly associated with an increased risk for meningococcal disease. 30141176 2019
CUI: C0025303
Disease: Meningococcal Infections
Meningococcal Infections
0.400 Biomarker group BEFREE Our study confirms the association of CFH with susceptibility to MD and strengthens the importance of this link in understanding pathogenesis of the disease. 27805046 2016
CUI: C0025303
Disease: Meningococcal Infections
Meningococcal Infections
0.400 GeneticVariation group BEFREE The CFH-CFHR3-CFHR1 aHUS-risk haplotype seems to be the same as was previously associated with protection against meningococcal infections, suggesting that the genetic variability in this region is limited to a few extended haplotypes, each with opposite effects in various human diseases. 26163426 2015
CUI: C0025303
Disease: Meningococcal Infections
Meningococcal Infections
0.400 Biomarker group BEFREE Our results support the conclusion that CFH is a critical determinant in acquiring meningococcal disease. 26135246 2015
CUI: C0025303
Disease: Meningococcal Infections
Meningococcal Infections
0.400 Biomarker group BEFREE The prevention of meningococcal disease may be improved by recombinant vaccines such as 4CMenB and rLP2086 that target the factor H binding protein (fHbp), an immunogenic surface component of Neisseria meningitidis present as one of three variants. 25247300 2014
CUI: C0025303
Disease: Meningococcal Infections
Meningococcal Infections
0.400 GeneticVariation group BEFREE These data may explain the association between genetic variation in both CFH and CFHR3 and susceptibility to meningococcal disease. 25534642 2014
CUI: C0025303
Disease: Meningococcal Infections
Meningococcal Infections
0.400 GeneticVariation group BEFREE Genetic variations in the gene cluster encoding IL-1 and in key genes including TNF, SP-A2 and CFH have been associated with susceptibility to meningococcal disease. 23409824 2013
CUI: C0025303
Disease: Meningococcal Infections
Meningococcal Infections
0.400 Biomarker group BEFREE Broad vaccine coverage predicted for a bivalent recombinant factor H binding protein based vaccine to prevent serogroup B meningococcal disease. 20619376 2010
CUI: C0025303
Disease: Meningococcal Infections
Meningococcal Infections
0.400 GeneticVariation group BEFREE Genome-wide association study identifies variants in the CFH region associated with host susceptibility to meningococcal disease. 20694013 2010
CUI: C0025303
Disease: Meningococcal Infections
Meningococcal Infections
0.400 Biomarker group CTD_human Genome-wide association study identifies variants in the CFH region associated with host susceptibility to meningococcal disease. 20694013 2010
CUI: C0025303
Disease: Meningococcal Infections
Meningococcal Infections
0.400 GeneticVariation group BEFREE This study shows that C-496T is both associated and linked with MD and that individuals possessing the fH C-496T C/C genotype are more likely to have increased serum fH protein levels, have reduced bactericidal activity against meningococci and be at an increased risk of contracting MD. 16938729 2006